[go: up one dir, main page]

AU3269793A - Method for obtaining recombinant surface antigen of hepatitis B, antigen and vaccine based on it - Google Patents

Method for obtaining recombinant surface antigen of hepatitis B, antigen and vaccine based on it

Info

Publication number
AU3269793A
AU3269793A AU32697/93A AU3269793A AU3269793A AU 3269793 A AU3269793 A AU 3269793A AU 32697/93 A AU32697/93 A AU 32697/93A AU 3269793 A AU3269793 A AU 3269793A AU 3269793 A AU3269793 A AU 3269793A
Authority
AU
Australia
Prior art keywords
antigen
hepatitis
vaccine based
obtaining recombinant
recombinant surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32697/93A
Inventor
Andrei Gennadievich Amosov
Vera Nikolaevna Borisova
Mikhail Valentinovich Budanov
Igor Viktorovich Krasilnikov
Lidiya Anatolievna Mikhailova
Mikhail Alexeevich Novikov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gensci Ltd
Original Assignee
Gensci Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SU5025798/14A external-priority patent/RU2045073C1/en
Priority claimed from SU5025861/14A external-priority patent/RU2045760C1/en
Application filed by Gensci Ltd filed Critical Gensci Ltd
Publication of AU3269793A publication Critical patent/AU3269793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
AU32697/93A 1991-12-27 1992-12-25 Method for obtaining recombinant surface antigen of hepatitis B, antigen and vaccine based on it Abandoned AU3269793A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SU5025798/14A RU2045073C1 (en) 1991-12-27 1991-12-27 Method of preparing recombinant surface antigen of hepatitis b
SU5025861/14A RU2045760C1 (en) 1991-12-27 1991-12-27 Method for preparing of recombinant surface antigen of hepatitis b
CN93101738A CN1090324A (en) 1991-12-27 1993-01-20 It is the antigen and the vaccine of base that the preparation method of hepatitis B recombinant chou surface antigen reaches with it

Publications (1)

Publication Number Publication Date
AU3269793A true AU3269793A (en) 1993-07-28

Family

ID=36793879

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32697/93A Abandoned AU3269793A (en) 1991-12-27 1992-12-25 Method for obtaining recombinant surface antigen of hepatitis B, antigen and vaccine based on it

Country Status (3)

Country Link
CN (1) CN1090324A (en)
AU (1) AU3269793A (en)
WO (1) WO1993012815A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100443117C (en) * 2003-05-13 2008-12-17 深圳康泰生物制品股份有限公司 Hepatitis B treating vaccine prepn and its prepn process and use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769238A (en) * 1981-08-04 1988-09-06 The Regents Of The University Of California Synthesis of human virus antigens by yeast
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
JPS60193925A (en) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst Lyophilized pharmaceutical preparation vaccine
FI861417A0 (en) * 1985-04-15 1986-04-01 Endotronics Inc HEPATITIS B YTANTIGEN FRAMSTAELLD MED REKOMBINANT-DNA-TEKNIK, VACCIN, DIAGNOSTISKT MEDEL OCH CELLINJER SAMT FOERFARANDEN FOER FRAMSTAELLNING DAERAV.
JPH089637B2 (en) * 1986-06-18 1996-01-31 財団法人阪大微生物病研究会 Hepatitis B virus antigen and method for producing the same
FR2608052B1 (en) * 1986-12-10 1990-04-13 Pasteur Vaccins PROCESS FOR THE PREPARATION OF A HEPATITIS B VACCINE AND VACCINE OBTAINED
FR2635532B1 (en) * 1988-07-29 1992-05-22 Pasteur Institut HYBRID RECOMBINANT HBSAG PARTICLES: MORPHOLOGICAL CHARACTERISTICS OF THE HBSAG ANTIGEN CONTAINING 1 IMMUNOGENIC SEQUENCE INDUCING NEUTRALIZING ANTIBODIES DIRECTED AGAINST HIV OR LIKELY TO BE RECOGNIZED BY SUCH ANTIBODIES; NUCLEOTIDE SEQUENCES ENCODING FOR SUCH PARTICLES; VACCINES CONTAINING THEM
GB9007024D0 (en) * 1990-03-29 1990-05-30 Imperial College Novel vaccine

Also Published As

Publication number Publication date
CN1090324A (en) 1994-08-03
WO1993012815A1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
AU9052091A (en) Vaccines based on hepatitis b surface antigen
AU709406C (en) Combined vaccines comprising hepatitis B surface antigen and other antigens
AU6304996A (en) Vaccines against hepatitis c
ZA97721B (en) Methods for retreatment of patients afflicted with hepatitis C using consensus interferon.
GB9324607D0 (en) Hepatitis c diagnostics and vaccines
AU4878096A (en) Hepatitis b vaccine
AU1471797A (en) Hybrid protein between CS from plasmodium and HBsAG
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
GB2264949B (en) Measles virus recombinant poxvirus vaccine
AU1257092A (en) Interferon sensitive recombinant poxvirus vaccine
EP0888777A3 (en) Recombinant bovine herpesvirus type 1 polyptpetides and vaccines
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
AU5679394A (en) Hepatitis b virus vaccines
AU1459792A (en) Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
AU3597089A (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
AU1522792A (en) Multiple hepatitis b virus surface proteins which form particles
AU3269793A (en) Method for obtaining recombinant surface antigen of hepatitis B, antigen and vaccine based on it
ZA929418B (en) Recombinant vaccines and method of producing same.
AU3232995A (en) Hepatitis a virus deletion mutants and vaccine formulations containing the same
AU2971692A (en) Flystrike antigen and vaccine and method for preparation
ZA932210B (en) A process for preparation of a recombinant hepatitis B surface antigen, and antigen and vaccine based thereon
AU5873094A (en) Multivalent ab1 antibodies as vaccines
GR3036125T3 (en) Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines.
AU6769594A (en) Hepatitis c virus immunodiagnostic antigens and antibodies